These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18506569)

  • 1. Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up.
    Topaloğlu R; Ayaz NA; Waterham HR; Yüce A; Gumruk F; Sanal O
    Clin Rheumatol; 2008 Oct; 27(10):1317-20. PubMed ID: 18506569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome.
    Shendi HM; Walsh D; Edgar JD
    Rheumatol Int; 2012 Jan; 32(1):249-51. PubMed ID: 20020131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.
    van der Hilst JCH; Bodar EJ; Barron KS; Frenkel J; Drenth JPH; van der Meer JWM; Simon A;
    Medicine (Baltimore); 2008 Nov; 87(6):301-310. PubMed ID: 19011501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 6 blockade for hyperimmunoglobulin D and periodic fever syndrome.
    Shendi HM; Devlin LA; Edgar JD
    J Clin Rheumatol; 2014 Mar; 20(2):103-5. PubMed ID: 24561416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome.
    Ozen S; Kuemmerle-Deschner JB; Cimaz R; Livneh A; Quartier P; Kone-Paut I; Zeft A; Spalding S; Gul A; Hentgen V; Savic S; Foeldvari I; Frenkel J; Cantarini L; Patel D; Weiss J; Marinsek N; Degun R; Lomax KG; Lachmann HJ
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):578-586. PubMed ID: 27723279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome.
    Takada K; Aksentijevich I; Mahadevan V; Dean JA; Kelley RI; Kastner DL
    Arthritis Rheum; 2003 Sep; 48(9):2645-51. PubMed ID: 13130485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperimmunoglobulin D syndrome in childhood.
    van der Hilst JC; Frenkel J
    Curr Rheumatol Rep; 2010 Apr; 12(2):101-7. PubMed ID: 20425018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.
    Rigante D; Ansuini V; Bertoni B; Pugliese AL; Avallone L; Federico G; Stabile A
    Rheumatol Int; 2006 Nov; 27(1):97-100. PubMed ID: 16871408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A taste of periodic fever syndromes.
    Koyfman A; Lovallo E; Hazen MM; Chiang VW
    Pediatr Emerg Care; 2013 Jul; 29(7):842-8; quiz 849-51. PubMed ID: 23823268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept.
    Arkwright PD; McDermott MF; Houten SM; Frenkel J; Waterham HR; Aganna E; Hammond LJ; Mirakian RM; Tomlin PI; Vijaydurai PI; Cant AJ
    Clin Exp Immunol; 2002 Dec; 130(3):484-8. PubMed ID: 12452839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of canakinumab in hyperimmunoglobulin D syndrome.
    Ozdemir Isik O; Karadag DT; Tekeoglu S; Yazici A; Cefle K; Cefle A
    Int J Rheum Dis; 2024 Jan; 27(1):e14857. PubMed ID: 37578023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to colchicine: anti-TNF drugs and FMF.
    Erten S; Erten SF; Altunoglu A
    Rheumatol Int; 2012 Apr; 32(4):1095-7. PubMed ID: 21431291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.
    De Benedetti F; Gattorno M; Anton J; Ben-Chetrit E; Frenkel J; Hoffman HM; Koné-Paut I; Lachmann HJ; Ozen S; Simon A; Zeft A; Calvo Penades I; Moutschen M; Quartier P; Kasapcopur O; Shcherbina A; Hofer M; Hashkes PJ; Van der Hilst J; Hara R; Bujan-Rivas S; Constantin T; Gul A; Livneh A; Brogan P; Cattalini M; Obici L; Lheritier K; Speziale A; Junge G
    N Engl J Med; 2018 May; 378(20):1908-1919. PubMed ID: 29768139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience.
    Kostjukovits S; Kalliokoski L; Antila K; Korppi M
    Eur J Pediatr; 2015 Jun; 174(6):707-14. PubMed ID: 25721923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents.
    Seyahi E; Ozdogan H; Celik S; Ugurlu S; Yazici H
    Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S99-103. PubMed ID: 17067437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response.
    Aróstegui JI; Solís P; Aldea A; Cantero T; Rius J; Bahíllo P; Plaza S; Vives J; Gómez S; Yagüe J
    Eur J Pediatr; 2005 Jan; 164(1):13-6. PubMed ID: 15549379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sacroileitis and pericarditis: atypical presentation of tumor necrosis factor receptor-associated periodic syndrome and response to etanercept therapy.
    Cantarini L; Lucherini OM; Cimaz R; Baldari CT; Laghi Pasini F; Galeazzi M
    Clin Exp Rheumatol; 2010; 28(2):290-1. PubMed ID: 20483057
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mevalonate kinase deficiency in 2016].
    Galeotti C; Georgin-Lavialle S; Sarrabay G; Touitou I; Koné-Paut I
    Rev Med Interne; 2018 Apr; 39(4):265-270. PubMed ID: 27659743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified regimen of etanercept for tumor necrosis factor receptor associated periodic syndrome (TRAPS) like illness.
    Dhanrajani A; Khubchandani RP
    Indian Pediatr; 2014 Jan; 51(1):55-7. PubMed ID: 24561467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoinflammatory Diseases with Periodic Fevers.
    Sag E; Bilginer Y; Ozen S
    Curr Rheumatol Rep; 2017 Jul; 19(7):41. PubMed ID: 28631068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.